Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy

BACKGROUND: Conversion surgery is a treatment that aims for R0 resection of primary advanced gastric cancers (GCs) that have responded well to systemic chemotherapy. We investigated the role of conversion therapy in initially unresectable metastatic cancer with positive HER2 status that responded to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanqiang, Xu, Xiaoqing, Hu, Can, Du, Yian, Ding, Guangyu, Chen, Jiahui, Zhu, Xiu, Xu, Zhiyuan, Wei, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372222/
https://www.ncbi.nlm.nih.gov/pubmed/35966292
http://dx.doi.org/10.21037/tcr-21-2886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372222/
https://www.ncbi.nlm.nih.gov/pubmed/35966292
http://dx.doi.org/10.21037/tcr-21-2886

Ejemplares similares